Medtronic updates AneuRx system
This article was originally published in The Gray Sheet
Executive Summary
A newer version of Medtronic's AneuRx AAAdvantage abdominal aortic aneurysm (AAA) stent graft with the Xcelerant delivery system wins FDA approval. Updates to the new system include improved radiopaque markers and stent contouring. Roughly 1.2 mil. people in the United States have AAA, though only 15% are ever diagnosed, according to Medtronic. The AneuRx system was originally launched in the U.S. in 1996 (1"The Gray Sheet" Nov. 28, 2005, p. 9)...
You may also be interested in...
Endovascular AAA Repair Requires Reintervention More Often Than Surgery
Reintervention to address abdominal aortic aneurysm (AAA) repair complications is more common following endovascular procedures than with open surgery, according to Vascular Surgery Chief Jan Blankensteijn, MD, Radboud University Nijmegen Medical Center, The Netherlands
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.